Evonile Pharma Limited (BOM:500672)
1,762.40
+48.05 (2.80%)
At close: Nov 6, 2026
Evonile Pharma Earnings Call Transcripts
Fiscal Year 2027
-
Q2 revenue fell amid the end of the legacy sales model, while transition charges and upfront hiring weighed on earnings. Distribution is in place, and management expects stabilization by Q4 FY 2027 or Q1 FY 2028, with a near-INR 600 crore annualized base.